APA

Vinson D., Molet-Benhamou L., Degboé Y., den Broeder A., Ibrahim F., Pontes C., Westhovens R., Závada J., Pham T., Barnetche T., Constantin A. & Ruyssen-Witrand A. (20210616). Impact of tapering targeted therapies (bDMARDs or JAKis) on the risk of serious infections and adverse events of special interest in patients with rheumatoid arthritis or spondyloarthritis: a systematic analysis of the literature and meta-analysis. : Arthritis research & therapy.

Chicago

Vinson D, Molet-Benhamou L, Degboé Y, den Broeder A, Ibrahim F, Pontes C, Westhovens R, Závada J, Pham T, Barnetche T, Constantin A and Ruyssen-Witrand A. 20210616. Impact of tapering targeted therapies (bDMARDs or JAKis) on the risk of serious infections and adverse events of special interest in patients with rheumatoid arthritis or spondyloarthritis: a systematic analysis of the literature and meta-analysis. : Arthritis research & therapy.

Harvard

Vinson D., Molet-Benhamou L., Degboé Y., den Broeder A., Ibrahim F., Pontes C., Westhovens R., Závada J., Pham T., Barnetche T., Constantin A. and Ruyssen-Witrand A. (20210616). Impact of tapering targeted therapies (bDMARDs or JAKis) on the risk of serious infections and adverse events of special interest in patients with rheumatoid arthritis or spondyloarthritis: a systematic analysis of the literature and meta-analysis. : Arthritis research & therapy.

MLA

Vinson D, Molet-Benhamou L, Degboé Y, den Broeder A, Ibrahim F, Pontes C, Westhovens R, Závada J, Pham T, Barnetche T, Constantin A and Ruyssen-Witrand A. Impact of tapering targeted therapies (bDMARDs or JAKis) on the risk of serious infections and adverse events of special interest in patients with rheumatoid arthritis or spondyloarthritis: a systematic analysis of the literature and meta-analysis. : Arthritis research & therapy. 20210616.